Charles Schwab Investment Management Inc Nuvalent, Inc. Transaction History

Charles Schwab Investment Management Inc

$521 Billion
Q1 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Nuvalent, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 317,764 shares of NUVL stock, worth $25.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

317,764

Previous 323,569 1.79%

Holding current value

$25.3 Million

Previous $25.3 Million 11.03%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$67.38 - $88.96 $391,140 - $516,412	-5,805 Reduced 1.79%	317,764 $22.5 Million
Q4 2024 Feb 06, 2025	BUY	$77.87 - $104.93 $602,869 - $812,368	7,742 Added 2.45%	323,569 $25.3 Million
Q3 2024 Nov 12, 2024	BUY	$67.44 - $112.17 $3.41 Million - $5.67 Million	50,536 Added 19.05%	315,827 $32.3 Million
Q2 2024 Aug 12, 2024	BUY	$62.76 - $81.61 $1.46 Million - $1.9 Million	23,247 Added 9.6%	265,291 $20.1 Million
Q1 2024 May 08, 2024	BUY	$72.35 - $88.99 $373,543 - $459,455	5,163 Added 2.18%	242,044 $18.2 Million
Q4 2023 Feb 06, 2024	BUY	$42.42 - $80.28 $1.65 Million - $3.12 Million	38,895 Added 19.65%	236,881 $17.4 Million
Q3 2023 Nov 08, 2023	BUY	$39.12 - $49.85 $5.14 Million - $6.55 Million	131,296 Added 196.88%	197,986 $9.1 Million
Q2 2023 Aug 09, 2023	BUY	$23.58 - $44.68 $225,778 - $427,811	9,575 Added 16.76%	66,690 $2.81 Million
Q1 2023 May 11, 2023	BUY	$25.42 - $33.52 $13,853 - $18,268	545 Added 0.96%	57,115 $1.49 Million
Q4 2022 Feb 13, 2023	BUY	$18.46 - $36.37 $204,407 - $402,725	11,073 Added 24.34%	56,570 $1.68 Million
Q3 2022 Nov 14, 2022	BUY	$13.55 - $19.92 $64,714 - $95,137	4,776 Added 11.73%	45,497 $885,000
Q2 2022 Aug 15, 2022	SELL	$7.4 - $15.07 $27,439 - $55,879	-3,708 Reduced 8.35%	40,721 $553,000
Q1 2022 May 13, 2022	BUY	$11.65 - $19.57 $201,044 - $337,719	17,257 Added 63.51%	44,429 $618,000
Q4 2021 Feb 11, 2022	BUY	$18.01 - $30.1 $20,603 - $34,434	1,144 Added 4.4%	27,172 $518,000
Q3 2021 Nov 16, 2021	BUY	$18.25 - $38.35 $475,011 - $998,173	26,028 New	26,028 $587,000

Others Institutions Holding NUVL

# of Institutions

213

Shares Held

60.9M

Call Options Held

311K

Put Options Held

175K

View Full List

About Nuvalent, Inc.

Ticker NUVL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,977,800
Market Cap $3.42B
Description
Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...

More about NUVL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Nuvalent, Inc. Transaction History